CSL Limited (OTCMKTS:CSLLY) Short Interest Update

CSL Limited (OTCMKTS:CSLLY) was the recipient of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 1,600 shares, a drop of 90.9% from the October 31st total of 17,500 shares. Based on an average daily volume of 89,900 shares, the short-interest ratio is presently 0.0 days.

CSL Price Performance

OTCMKTS:CSLLY traded up $0.89 during trading hours on Wednesday, hitting $91.19. The company’s stock had a trading volume of 34,189 shares, compared to its average volume of 35,444. CSL has a 52-week low of $82.55 and a 52-week high of $109.00. The business’s 50-day moving average is $96.31 and its two-hundred day moving average is $98.21. The company has a current ratio of 2.18, a quick ratio of 0.97 and a debt-to-equity ratio of 0.58.

Wall Street Analyst Weigh In

Separately, Macquarie upgraded CSL to a “strong-buy” rating in a research report on Tuesday, August 13th.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.